Hepabig Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Human hepatitis B Ig

Indications/Uses

Prophylaxis of hepatitis B after exposure to HBsAg. Prophylaxis of hepatitis B in neonates.

Click to view Hepabig detailed prescribing information

Dosage/Direction for Use

IM Exposure to HBsAg Adult Recommended dose: 1,000-2,000 IU. If necessary, may increase or repeat dose. Childn 32-48 IU/kg. Administer w/in 7 days after exposure to HBsAg (preferably w/in 48 hr). Neonate Initially 100-200 IU. 1st dose: Administer w/in 5 days after birth (preferably w/in 48 hr). Booster dose: Administer 32-48 IU/kg between 2-3 mth after the 1st administration.

Click to view Hepabig detailed prescribing information

Contraindications

HBsAg +ve individuals.

Click to view Hepabig detailed prescribing information

Special Precautions

Patients w/ IgA deficiency syndrome. Should not be administered IV. 1 dose of 1 mL inj should be done at 2 different sites in neonates.

Click to view Hepabig detailed prescribing information

Adverse Reactions

Local pain, swelling & induration at the inj site. Occasional rash & fever.

Click to view Hepabig detailed prescribing information

Storage

View Hepabig storage conditions for details to ensure optimal shelf-life.

Description

View Hepabig description for details of the chemical structure and excipients (inactive components).

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J06BB04 - hepatitis B immunoglobulin ; Belongs to the class of specific immunoglobulins. Used in passive immunizations.

Regulatory Classification

Presentation/Packing

Form

Hepabig inj 100 IU/0.5 mL

Packing/Price

1's

Hepabig

hepatitis b immunoglobulin

Manufacturer:

Green Cross Corp

Distributor:

Vizcarra Pharma